Indian biopharma firm Biocon has announced the signing of partnership agreement with Bahiafarma and Bionovis for Pertuzumab ...
Australia’s first viral vector Contract Development and Manufacturing Organisation (CDMO) has announced that the Therapeutic ...
Japan-based company NIPRO has maintained a presence in Singapore since 1997. Ahead of NIPRO Asia's 30th anniversary in 2027, ...
The investment reflects Novo Holdings' conviction in the long-term growth of advanced wound care, increasing global demand ...
Lunit partners with 10x Genomics to Integrate AI-Enabled Pathology Analysis with Spatial Molecular Data for Oncology Clinical ...
Bracco Imaging has launched the BubbleGen CD3+ T Cell Selection Kit, extending its microbubble-based, magnetic bead-free ...
At the launch of the ASEAN Care Readiness Index 2026, Lars Wismer joined Dr May-Anne Cheong of Singapore General Hospital and ...
Indian biotechnology company Immunoscript Life Science will receive up to $8.9 million from Norway-based Coalition for Epidemic Preparedness Innovations (CEPI)to advance clinical ...
The Taiwan Excellence Pavilion officially opened on 9 Sept at Medical Fair Asia 2026, held at the Sands Expo & Convention Centre. Organised by TITA (International Trade Administra ...
Minoryx Therapeutics and Neuraxpharm have completed enrolment in the global Phase III CALYX trial of leriglitazone in adult cerebral adrenoleukodystrophy, with top-line results expected in early 2028.
The Career Spotlight edition traces how 50 leaders across biopharma, life sciences and medtech reached the top job, revealing ...
BioSpectrum is an integrated B2B media platform for the healthcare and bioscience industry in the Asia Pacific region.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results